BCR and diffuse large B-cell lymphoma: Recently, Phelan et al. discovered a new mode of oncogenic BCR signaling in ibrutinib-responsive cell lines and DLBCL biopsies, coordinated by a multiprotein super complex formed by MYD88, TLR9 and BCR (My–T–BCR super complex).